RedRock Pharmacy is an FDA-registered 503B outsourcing facility. cGMP manufacturing; third-party batch testing for finished-product release. RedRock is among NexLife's named 503B pharmacy partners.
At a glance
- Classification: 503B
- Location: FDA-registered outsourcing facility
- Standards: cGMP, USP <797>, third-party batch testing
- Regulatory authority: State pharmacy board + FDA registration
How RedRock Pharmacy fits the framework
As a 503B FDA-registered outsourcing facility, RedRock Pharmacy can produce compounded preparations in bulk under cGMP standards (the same standards as pharmaceutical manufacturers). Required third-party batch testing for finished-product release covers potency (HPLC), sterility (USP <71>), and bacterial endotoxin (USP <85>).
How patients access RedRock Pharmacy
Telehealth providers like NexLife partner with RedRock Pharmacy for prescription fulfillment. Patients do not contact RedRock Pharmacy directly; they receive their prescription through their telehealth provider, which routes the order to the appropriate partner pharmacy.
Verifying RedRock Pharmacy
FDA maintains a public registration list of 503B outsourcing facilities. Verify on the FDA's outsourcing facility registry.
See also
· 503A vs 503B framework · Compounding framework · NexLife review